1-Methyleffusol Synthesis for Larger-Scale Bone Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The naturally occurring compound 1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol (1-Methyleffusol) is scarce in Juncus effusus, limiting its availability for biological and pharmaceutical studies, necessitating the development of methods for its synthesis at larger scales.
Innovation Solution
A multi-step synthetic process involving refluxing, hydrogenation, bromination, oxidative coupling, demethylation, and Suzuki-coupling reactions to produce 1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol, followed by purification and potential conversion into pharmaceutically acceptable salts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If 1-Methyleffusol is isolated from Juncus effusus, then the compound can be obtained with high purity, but the yield is extremely low (0.75 to 5 ppm) and the process is inefficient
Solution Approach 1:
The patent divides the synthesis of 1-Methyleffusol into multiple discrete steps (Wittig reaction, hydrogenation, bromination, oxidative coupling, demethylation, Suzuki coupling), where each step produces a specific intermediate compound. This segmentation allows for optimized conditions at each stage and facilitates purification and characterization of intermediates, resolving the contradiction between purity and yield by enabling systematic quality control throughout the synthesis pathway.
Solution Approach 2:
The patent employs preliminary protection strategies by introducing methoxy groups at strategic positions during early synthesis stages, which are later removed to reveal the final diol structure. This preliminary action allows the molecule to be built with protective groups that prevent unwanted reactions, ensuring high purity of intermediates while maintaining overall yield through minimized side reactions.
2Productivity
If a multi-step synthesis method is used to produce 1-Methyleffusol, then the yield and scalability are improved, but the device complexity and process difficulty increase
Solution Approach 1:
The patent employs universal reagents and conditions across multiple synthesis steps. For example, standard Wittig reagents, catalytic hydrogenation conditions, and Suzuki coupling protocols are used, which are well-established and can be performed with常规 laboratory equipment. This universality reduces device complexity while maintaining high productivity, as the same general types of reactions and equipment can be used throughout the synthesis pathway.
Solution Approach 2:
The patent systematically varies reaction parameters (temperature, solvent, catalyst, stoichiometry) for each transformation step to optimize yield and selectivity. By carefully controlling parameters such as reflux temperature during Wittig reaction, hydrogen pressure during hydrogenation, and base concentration during oxidative coupling, the process achieves high productivity while managing complexity through parameter optimization rather than equipment complexity.
3Ease of manufacture
If natural sources are used for 1-Methyleffusol, then no synthesis steps are required, but the quantity available is insufficient for pharmaceutical studies
Solution Approach 1:
The patent uses preliminary action by preparing phosphonium salts and other reagents in advance before the main synthesis sequence. This allows the actual assembly of the 1-Methyleffusol molecule to proceed efficiently without interruption, achieving both simplicity (pre-prepared reagents) and quantity (continuous synthesis capability) simultaneously.
Solution Approach 2:
The patent establishes a continuous synthesis pathway where each step feeds into the next without interruption. Intermediate compounds are carried forward through the sequence (Wittig → hydrogenation → bromination → oxidative coupling → demethylation → Suzuki coupling), maintaining continuous productive action that overcomes the quantity limitation of natural sources while keeping the process manageable through systematic continuity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables the production of 1-Methyleffusol in sufficient quantities for pharmaceutical compositions, which can stimulate bone formation and treat related conditions.
Implementation Method 1
refluxing the phosphonium bromide and 3-methoxy-2-methylbenzaldehyde in an alkaline solution to afford (Z)- and (E)-1,2-bis(3-methoxy-2-methylphenyl)ethene stereoisomers
Implementation Method 2
hydrogenating the (Z)- and (E)-1,2-bis(3-methoxy-2-methylphenyl)ethene stereoisomers to afford 1,2-bis(3-methoxy-2-methylphenyl)ethane
Implementation Method 3
brominating the 1,2-bis(3-methoxy-2-methylphenyl)ethane to afford 5-bromo-1-methoxy-3-(3-methoxy-2- methylphenethyl)-2-methylbenzene
Implementation Method 4
oxidatively coupling the 5-bromo-1-methoxy-3-(3-methoxy-2-methylphenethyl)-2-methylbenzene to afford 4-bromo-2,7-dimethoxy-1,8-dimethyl-9,10-dihydrophenanthrene
Implementation Method 5
demethylating the 4-bromo-2,7-dimethoxy-1,8-dimethyl-9,10-dihydrophenanthrene to afford 4-bromo-1,8-dimethyl-9,10-dihydrophenanthrene- 2,7-diol
Implementation Method 6
subjecting the 4-bromo-1,8-dimethyl-9,10-dihydrophenanthrene- 2,7-diol to a Suzuki-coupling reaction with a vinyl trifluoroborate salt and a palladium salt to afford 1,8-dimethyl-4-vinyl-9,10-dihydrophenanthrene-2,7-diol
Data Source
AI summary
Methods of making 1-methyleffusol are described herein. The 1-methyleffusol compound, and pharmaceutical compositions thereof, can be used to stimulate bone forming activities in a subject in need thereof.